AN2 Therapeutics, Inc. (ANTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for AN2 Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.98x | -0.80x | -7.47x | -3.57x | -13.40x | -21.22x |
| P/B Ratio | 0.65x | 0.50x | 3.88x | 1.53x | 4.66x | 104.91x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.87x | 8.43x | 7.87x | 13.72x | 17.70x | 2.90x |
| Quick Ratio | 6.87x | 8.43x | 7.87x | 13.72x | 17.70x | 2.90x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..